Terns Pharmaceuticals Inc. (TERN) NASDAQ

$5.06 (0.08) (-1.56%)

Market Cap: $332.31M

As of 04/15/24 03:59 PM EDT. Market closed.

(TERN)

Terns Pharmaceuticals Inc. (TERN)
NASDAQ

$5.06
(0.08) (-1.56%)

Market Cap: $332.31M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

terns pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers. the company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in china to advance its growing pipeline of ... read more

terns pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers. the company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in china to advance its growing pipeline of drugs that are optimized against clinically-validated targets. based in san mateo, california and shanghai, terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in china and globally. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
Full Time Employees
44
Address
.
PRICE CHART FOR TERNS PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.07
Previous Close
$5.14
Days Range
$5.01 - $5.25
52 week range
$3.26 - $14.04
Volume
695,545
Avg. Volume (30 days)
1,010,508
Market Cap
$332.31M
Dividend Yield
-
P/E
-
Shares Outstanding
64,651,693
Open
$5.07
Previous Close
$5.14
Days Range
$5.01 - $5.25
52 week range
$3.26 - $14.04
Volume
695,545
Avg. Volume (30 days)
1,010,508
Market Cap
$332.31M
Dividend Yield
-
P/E
-
Shares Outstanding
64,651,693
FINANCIAL STATEMENTS FOR TERNS PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TERNS PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Vivo Opportunity, LLC10% OwnerApr 02, 2024 Sale$6.6576,346507,7014,127,611Apr 03, 2024, 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 01, 2024 Sale$6.995,45138,102275,772Apr 03, 2024, 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 03, 2024 Sale$6.204,14925,724268,573Apr 03, 2024, 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 01, 2024 Sale$6.9939,411275,4831,997,146Apr 03, 2024, 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 03, 2024 Sale$6.2030,047186,2911,945,015Apr 03, 2024, 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 01, 2024 Sale$6.99136,255952,4224,203,957Apr 03, 2024, 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 03, 2024 Sale$6.20103,870643,9944,023,741Apr 03, 2024, 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 02, 2024 Sale$6.653,05020,283272,722Apr 03, 2024, 08:47 PM
Vivo Opportunity, LLC10% OwnerApr 02, 2024 Sale$6.6522,084146,8591,975,062Apr 03, 2024, 08:47 PM
Yoon Seokho BryanCOO and General CounselNov 30, 2023 Buy$3.787432,80918,399Dec 04, 2023, 06:03 PM
Vignola Mark J.Chief Financial OfficerNov 30, 2023 Buy$3.787432,80918,399Dec 04, 2023, 06:03 PM
Vignola Mark J.Chief Financial OfficerMay 31, 2023 Buy$1.419,99714,09617,656Jun 02, 2023, 05:03 PM
Yoon Seokho BryanCOO and General CounselMay 31, 2023 Buy$1.419,99714,09617,656Jun 02, 2023, 05:03 PM
Sundaram Senthil VelChief Executive OfficerMay 31, 2023 Buy$1.412,1112,9779,770Jun 02, 2023, 05:03 PM
Yoon Seokho BryanCOO and General CounselNov 30, 2022 Buy$1.41347,659Feb 03, 2023, 06:01 PM
Vignola Mark J.Chief Financial OfficerNov 30, 2022 Buy$1.41347,659Feb 03, 2023, 06:01 PM
Sundaram Senthil VelChief Executive OfficerNov 30, 2022 Buy$1.41347,659Feb 03, 2023, 06:00 PM
ORBIMED ADVISORS LLCDirectorDec 23, 2022 Buy$7.25137,9311,000,0004,882,854Dec 28, 2022, 05:57 PM
GORDON CARL LDirectorDec 23, 2022 Buy$7.25137,9311,000,0004,882,854Dec 28, 2022, 05:46 PM
Vivo Opportunity, LLC10% OwnerDec 23, 2022 Buy$7.25758,6205,499,9954,340,212Dec 23, 2022, 05:48 PM
Lu HongboDirectorDec 23, 2022 Buy$7.25758,6205,499,9954,340,212Dec 23, 2022, 05:44 PM
LAV Biosciences Fund V, L.P.10% OwnerNov 23, 2022 Sale$5.501,500,0008,250,0001,059,523Nov 28, 2022, 04:56 PM
Vivo Opportunity, LLC10% OwnerSep 07, 2022 Buy$3.60600,0002,160,0003,581,592Sep 08, 2022, 08:00 PM
Lu HongboDirectorSep 07, 2022 Buy$3.60600,0002,160,0003,581,592Sep 08, 2022, 08:00 PM
ORBIMED ADVISORS LLCDirectorAug 16, 2022 Buy$2.423,690,0008,929,8004,744,923Aug 18, 2022, 05:00 PM
GORDON CARL LDirectorAug 16, 2022 Buy$2.423,690,0008,929,8004,744,923Aug 18, 2022, 04:50 PM
Vivo Opportunity, LLC10% OwnerAug 16, 2022 Buy$2.421,500,0003,630,0002,981,592Aug 16, 2022, 08:44 PM
Vivo Opportunity, LLC10% OwnerAug 15, 2022 Buy$2.991,2183,6421,481,592Aug 16, 2022, 08:44 PM
Vivo Opportunity, LLC10% OwnerAug 12, 2022 Buy$2.981,123,0213,346,6031,480,374Aug 16, 2022, 08:44 PM
Lu HongboDirectorAug 12, 2022 Buy$2.981,123,0213,346,6031,480,374Aug 16, 2022, 08:30 PM
Lu HongboDirectorAug 16, 2022 Buy$2.421,500,0003,630,0002,981,592Aug 16, 2022, 08:30 PM
Lu HongboDirectorAug 15, 2022 Buy$2.991,2183,6421,481,592Aug 16, 2022, 08:30 PM
Yoon Seokho BryanCOO and General CounselMay 31, 2022 Buy$1.477,65611,2547,656Jun 08, 2022, 09:28 PM
Vignola Mark J.Chief Financial OfficerMay 31, 2022 Buy$1.477,65611,2547,656Jun 08, 2022, 09:27 PM
Sundaram Senthil VelChief Executive OfficerMay 31, 2022 Buy$1.477,65611,2547,656Jun 08, 2022, 09:27 PM
GORDON CARL LDirectorFeb 09, 2021 Buy$17.00475,0008,075,0002,274,723Feb 09, 2021, 03:10 PM
ORBIMED ADVISORS LLCDirectorFeb 09, 2021 Buy$17.00475,0008,075,0002,274,723Feb 09, 2021, 03:09 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Buy$17.00357,3536,075,001357,353Feb 09, 2021, 03:08 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Buy$17.0014,275242,675281,223Feb 09, 2021, 03:08 PM
Vivo Capital VIII, LLC10% OwnerFeb 09, 2021 Buy$17.00103,3721,757,3242,036,557Feb 09, 2021, 03:08 PM
Flynn James E10% OwnerFeb 09, 2021 Buy$17.00665,00011,305,0002,382,033Feb 09, 2021, 02:55 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Vivo Opportunity, LLC10% Owner04/02/2024507,701
Vivo Opportunity, LLC10% Owner04/01/202438,102
Vivo Opportunity, LLC10% Owner04/03/202425,724
Vivo Opportunity, LLC10% Owner04/01/2024275,483
Vivo Opportunity, LLC10% Owner04/03/2024186,291
Vivo Opportunity, LLC10% Owner04/01/2024952,422
Vivo Opportunity, LLC10% Owner04/03/2024643,994
Vivo Opportunity, LLC10% Owner04/02/202420,283
Vivo Opportunity, LLC10% Owner04/02/2024146,859
Yoon Seokho BryanCOO and General Counsel11/30/20232,809
Vignola Mark J.Chief Financial Officer11/30/20232,809
Vignola Mark J.Chief Financial Officer05/31/202314,096
Yoon Seokho BryanCOO and General Counsel05/31/202314,096
Sundaram Senthil VelChief Executive Officer05/31/20232,977
Yoon Seokho BryanCOO and General Counsel11/30/20224
Vignola Mark J.Chief Financial Officer11/30/20224
Sundaram Senthil VelChief Executive Officer11/30/20224
ORBIMED ADVISORS LLCDirector12/23/20221,000,000
GORDON CARL LDirector12/23/20221,000,000
Vivo Opportunity, LLC10% Owner12/23/20225,499,995
Lu HongboDirector12/23/20225,499,995
LAV Biosciences Fund V, L.P.10% Owner11/23/20228,250,000
Vivo Opportunity, LLC10% Owner09/07/20222,160,000
Lu HongboDirector09/07/20222,160,000
ORBIMED ADVISORS LLCDirector08/16/20228,929,800
GORDON CARL LDirector08/16/20228,929,800
Vivo Opportunity, LLC10% Owner08/16/20223,630,000
Vivo Opportunity, LLC10% Owner08/15/20223,642
Vivo Opportunity, LLC10% Owner08/12/20223,346,603
Lu HongboDirector08/12/20223,346,603
Lu HongboDirector08/16/20223,630,000
Lu HongboDirector08/15/20223,642
Yoon Seokho BryanCOO and General Counsel05/31/202211,254
Vignola Mark J.Chief Financial Officer05/31/202211,254
Sundaram Senthil VelChief Executive Officer05/31/202211,254
GORDON CARL LDirector02/09/20218,075,000
ORBIMED ADVISORS LLCDirector02/09/20218,075,000
Vivo Capital VIII, LLC10% Owner02/09/20216,075,001
Vivo Capital VIII, LLC10% Owner02/09/2021242,675
Vivo Capital VIII, LLC10% Owner02/09/20211,757,324
Flynn James E10% Owner02/09/202111,305,000
Load More Insider Transactions
FUNDS WITH A POSITION IN TERNS PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC7,619,1350.99%No changeOther
VIVO CAPITAL, LLC6,657,9923.54%No changeOther
SUVRETTA CAPITAL MANAGEMENT, LLC5,837,1261.71%-3.39%Growth At A Reasonable Price
BLACKROCK INC.3,408,9780.00056%7.71%Other
DRIEHAUS CAPITAL MANAGEMENT LLC1,130,0520.09%-30.15%Growth
ADAGE CAPITAL PARTNERS GP, L.L.C.1,050,0000.01%950%Other
GEODE CAPITAL MANAGEMENT, LLC840,4590.00057%6.64%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)17,2900.00207%NewOther
BALYASNY ASSET MANAGEMENT L.P.13,8540.00017%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR TERNS PHARMACEUTICALS INC
STOCK BUYBACKS FOR TERNS PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
1.14%
1Q
12/31/2023
06/30/2023
1.37%
2Q
12/31/2023
03/31/2023
3.68%
3Q
12/31/2023
09/30/2022
87.85%
5Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
1.14%
1Q
06/30/2023
1.37%
2Q
03/31/2023
3.68%
3Q
09/30/2022
87.85%
5Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TERNS PHARMACEUTICALS INC
LOADING...